SCHEMBL6369259

SCHEMBL6369259

c1ccc(CC(=Nc2ccccc2)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.51
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.42
SLC22A2 O15244 2/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
AKR1B1 P15121 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC22A3 O75751 1/20 0.41
HTR3B O95264 1/20 0.41
PLAU P00749 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16382907 0.87 CYP2D6 (0.46) CTSLMEN1KMT2AATMSLC22A2
SCHEMBL15073455 0.83 SMN1; SMN2 (0.55) CES2CES1HTR3EHTR3BPLAU
SCHEMBL16336153 0.83 SMN1; SMN2 (0.55) CES2CES1HTR3EHTR3BPLAU
SCHEMBL16336154 0.83 SMN1; SMN2 (0.55) CES2CES1HTR3EHTR3BPLAU
SCHEMBL16336372 0.79 SMN1; SMN2 (0.59) MEN1KMT2AHTR3EHTR3BPLAU
SCHEMBL15073451 0.79 SMN1; SMN2 (0.59) MEN1KMT2AHTR3EHTR3BPLAU
SCHEMBL16336373 0.79 SMN1; SMN2 (0.59) MEN1KMT2AHTR3EHTR3BPLAU
SCHEMBL9541668 0.78 KMT2A (0.50) MEN1KMT2AATMSLC22A2CES1
SCHEMBL4586157 0.78 CTSL (0.55) CTSLATMCES2CES1AKR1B1
SCHEMBL257218 0.78 CTSL (0.55) CTSLATMCES2CES1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107608-A1 Ligands for use in catalytic processes EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH ETHZ (CH) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107608-A1 Ligands for use in catalytic processes PNKP, ITPA, PLCG2 CTSL 722/4885MEN1 3026/4885KMT2A 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.